MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
52.71
-1.02 (-1.90%)
At close: Aug 19, 2025, 3:59 PM
52.66
-0.09%
After-hours: Aug 19, 2025, 04:10 PM EDT
-1.90% (1D)
| Bid | 50 |
| Market Cap | 3.35B |
| Revenue (ttm) | 101.85K |
| Net Income (ttm) | -176.47M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -18.89 |
| Forward PE | -13.04 |
| Analyst | Buy |
| Ask | 57.43 |
| Volume | 294,092 |
| Avg. Volume (20D) | 533,359 |
| Open | 53.41 |
| Previous Close | 53.73 |
| Day's Range | 52.40 - 53.80 |
| 52-Week Range | 31.42 - 58.26 |
| Beta | 1.27 |
About MLTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MLTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+17.95%
MoonLake Immunotherapeutics shares are trading hig...
Unlock content with
Pro Subscription
2 months ago
+5.51%
MoonLake Immunotherapeutics shares are trading higher following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.
2 months ago · seekingalpha.com
MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma InterestMoonLake Immunotherapeutics completed enrollment of the two phase 3 VELA studies using Sonelokimab for the treatment of patients with hidradenitis suppurativa. The global psoriatic arthritis market is...
